OSM and metabolic dysfunction-associated steatohepatitis: Interestingly, OSM was selectively overexpressed in hepatic cancer cells and progressively increased with the tumor grade, with serum OSM levels being enhanced as well and correlated with a poor outcome, suggesting OSM as a putative prognostic factor for NASH-associated HCC [59].